Sort
40,608 grants matching “prostate cancer”
PROSTATE CANCER BIOREPOSITORY NETWORK (PCBN)
$830,620New York University · · FY2018 · Defense Health Agency
Beaumont Community Clinical Oncology Program
$830,438William Beaumont Hospital Research Inst · U10 · FY2004 · CA
Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening
$829,937Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MD
Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening
$829,767Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MD
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2020 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2019 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2018 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2021 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Molecular prediction of myeloma in African Americans
$829,309Irene M. Ghobrial · Dana-Farber Cancer Inst · U01 · FY2024 · CA
Translational Pathology Core Facility
$829,092Sue Ellen Martin · University Of Southern California · P30 · FY2010 · CA
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
$829,004Joan M Lappe · Creighton University · R01 · FY2009 · CA
Mechanisms of Inorganic Carcinogenesis
$828,727Michael Waalkes · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Etiologic Studies of Prostate Cancer
$828,439Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Liver Cancer Disparities in Alaska Native and American Indian People
$828,416George Ioannou · University Of Washington · P20 · FY2023 · CA
Bioinfomatics
$828,317Nicholas Socci · Sloan-Kettering Inst Can Research · P30 · FY2017 · CA
Identification of epigenetic drivers of advanced prostate cancer
$828,107David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mechanism of epigenetic activation during disease progression
$828,107David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Center for Applied Preclinical Research (CAPR)
$828,050Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Howard/Hopkins Cancer Centers Partnership
$828,029Johns Hopkins University · U54 · FY2005 · CA
Core 2
$827,811Andrea Califano · Columbia University Health Sciences · U54 · FY2012 · CA
TARGETING HOMOLOGY-DIRECTED RECOMBINATIONAL REPAIR (HDR) OF CHROMOSOMAL BREAKS TO SENSITIZE PROSTATE CANCER CELLS TO POLY (ADP-RIBOSE) POLYMERASE (PA
$827,648University Of Alabama At Birmingham · · FY2010 · Department of Defense
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER
$827,400Dana-Farber Cancer Institute · U01 · FY2003 · CA
Signal Transduction Events and the Regulation of Cell Growth
$827,195Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2011 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER
$826,761Dana-Farber Cancer Institute · U01 · FY2001 · CA